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Changes in Practice
• Eliminate the use of assisted airway clearance
for disease processes for which it is not
indicated
• Use physiologically and age appropriate
methods of assisted airway clearance when
indicated

Goals and Objectives
• Describe normal airway clearance and the disease
processes for which assisted airway clearance therapy is
indicated
• Explain the physiologic rationale for and data supporting
use of various assisted airway clearance techniques
used among children
• Develop an age and diagnosis appropriate airway
clearance plan for a child with impaired airway clearance

Normal Airway Clearance
• Airway anatomy and physiology
• Respiratory Epithelium
• Innate airway clearance mechanisms
– Cough
– Mucociliary Escalator
– Cephalad Airflow Bias

https://accessmedicine.mhmedical.com/data/books/ga
no24/gano24_c034f001b.png

Cilia

Muscle

Glands

Yes

Yes

Diffuse

Yes

Yes

Scattered
Sparse

Yes

Yes

No

Some

Some

No

Minimal

Minimal

No

None

No

No

Conducting Zone
• Cough
• Cephalad airflow bias
• Mucociliary escalator

Respiratory Zone
• Cephalad airflow bias
• Alveolar macrophages
• Chemical absorption

Respiratory Epithelium
• Large airways are rich in goblet
cells and submucosal glands
which produce mucus
• Medium airways have
decreasing quantities of goblet
cells and submucosal glands
• Small airways (bronchioles and
distal) do not produce mucus
https://basicmedicalkey.com/wp-content/uploads/2016/06/m_bar_ch34_f002.png

Cough
• Healthy children cough
up to 11 times per day airway protection,
normal airway clearance
• Reflex
–
–
–
–

Deep inspiration
Glottic closure
Muscle contraction
Glottic opening

Control Center (tractus
solitaris & respiratory
control center)

Chemo- and MechanoReceptors (rapidly
adapting, slowly adapting,
C-fibers): nasopharynx,
larynx, lower airways,
interstitium, diaphragm,
and esophagus

Effectors
(nasopharyngeal,
laryngeal, accessory,
intercostal, diaphragm,
abdominal)
https://www.netterimages.com/the-respiratory-system-unlabeledpulmonary-medicine-frank-h-netter-914.html

Mucociliary Escalator
•
•
•
•

•

Gel Layer (high viscosity and
elasticity)
Sol Layer (low viscosity and
elasticity)
Rapid movement in extension to
propel material in gel phase
Slow return in flexion to starting
position, traveling through sol phase
Most effective in small airways due to
large cross-sectional area
http://erj.ersjournals.com/content/23/1/146

Cephalad Airflow Bias
•

•

•

Decreased airway diameter
during exhalation results in
increased flow velocity
Increased airflow velocity
shears secretions and drives
material in direction of flow
Present in large and small
airways but is the primary
mechanism of transport in
smaller conducting airways

http://www.rcjournal.com/contents/09.07/09.07.1210.pdf

Physiologic Approach to AACT
• Disease processes for which AACT is indicated
– Increased airway secretions
• Inhalation/aspiration injuries

– Impaired clearance of secretions
• Impaired mucociliary clearance
– Bronchiectasis; CF
– PCD

– Decreased cough efficacy
• Neuromuscular weakness

• Disease processes for which AACT is not
indicated
– Bronchiolitis
• Numerous poor quality studies demonstrating conflicting results
• Several Cochrane reviews citing no evidence of benefit

– Pneumonia
• No physiologic rationale for use
• No studies indicating benefit
• Cochrane reviews citing no evidence of benefit

– Asthma
• Multiple studies and reviews demonstrating no benefit

– Routine post-operative management
• No literature to support routine use
– Appropriate for patients with underlying disease
– Appropriate for significant post-operative atelectasis

– Mechanically ventilated patients
• Several studies failing to demonstrate benefit
– Associated with  O2 saturations and  HR, ICP, BP

• Potential use in patients with significant atelectasis

• Physiologically appropriate AACT
– Conducting Zone
• Improve cough efficacy
• Enhance function of mucociliary escalator
• Increase cephalad airflow bias

– Respiratory Zone
• Increase cephalad airflow bias
• Nothing to stimulate alveolar macrophages
• Nothing to alter chemical absorption

AIRWAY CLEARANCE THERAPIES

One of My Many Pet Peeves
What is CPT?
PDP
Assisted Airway Clearance

Breathing Techniques/Exercises
Chest
Physiotherapy

Thoracic Cage Exercises
Cardiopulmonary Conditioning
Aerosol Therapy
Other

Breathing Techniques

AD
ACBT

Devices

HFCWO
PEP/OPEP
IPV
Cough Assist

CPT ≠ AACT≠ PDP

Postural Drainage and Percussion
• Physiology
– “Gold Standard” for airway clearance for many years
– Postural drainage relies on gravity-enhanced secretion
clearance
– Percussion helps to vibrate airways, shearing
secretions
– Vibration largely abandoned

• Therapy
– Use 6-12 positions
– Percussion of 3-4 minutes per
position
– Controlled breathing and
huffing/FET maneuvers between
positions
– Contraindicated in circumstances
where there are concerns for 
ICP, HTN, hemoptysis, GERD,
coagulopathy, etc.

https://clinicalgate.com/wp-content/uploads/2015/06/B9780323082037000403_f040002-9780323082037.jpg

• Pro
–
–
–
–

All ages
No cost (time)
Portable
Familiarity and ease of use

• Con
–
–
–
–

Passive
Requires providers
GERD
Hypoxemia

• Data
–  sputum volume
–  FVC and PEF immediately after
treatment
–  spirometry without therapy
– Meta-analysis suggests that any
therapy is better than no therapy
– Cochrane reviews: no compelling
evidence that airway clearance is
beneficial for long-term use;
limited support for short-term use

Autogenic Drainage
• Physiology
– Developed in late 1960’s in Belgium
– Tidal breathing at various lung volumes starting from
low to high
– “Milks” secretions from smaller to larger airways by
producing high-velocity air flow in different generations
of airways
– Huff at end of cycle allows clearance from largest ways

IRV

TV

ERV

Unstick

Collect

Evacuate

• Pro
–
–
–
–

Active
Independence
No cost
Portable

• Con
– Motivated, intelligent, older (>
12 years) patient
– Difficult to learn

• Data
–
–
–
–

 sputum expectoration
 desaturation
As effective as PDP
Preferred to PDP by patients

Active Cycle of Breathing Technique
• Physiology
– Developed in late 1960’s in New Zealand
– Combines breathing control exercises (BC), thoracic
expansion exercises (TEE), and huffing
– TEE lead to greater collateral ventilation and movement
of secretions from peripheral to central airways
– Huffing allows expectoration of accumulated secretions

BC

Huff

TEE

IRV
BC

TV
Huff

BC

ERV

FET

BC

TEE

BC

Huff

TEE

TEE

Huff

BC

• Pro
–
–
–
–

Active
Independence
No cost
Portable

• Con
– Motivated, intelligent, older (>
12 years) patient

• Data
– Equivalent to PDP
–  desaturation
–  independence

HFCWO
• Physiology
–
–
–
–
–

Decreases mucus viscosity
Increases cough-like shear forces
Increases airflow bias
Mechanical vibration of airways
Increased cilia beat frequency

• Systems
– Air pulse generator, large bore tubing, inflatable vests
– Variable pressures generated
– Variable frequencies possible

• Therapy
– 20-30 minutes at least BID and
more often during illness
– Vary frequency to move
secretions from smaller to
larger airways
– Intermittent deep breathing
and huffs between frequencies

• Pro
– Independence
– Ages > 2 years
– Easy to use

• Con
– Passive
– Cost
– Lack of portability

• Data
– Equivalent to PDP with respect
to spirometry
–  sputum clearance
– Improved sputum rheology
–  patient satisfaction

PEP and OPEP
• Physiology
– Prevents airway collapse by
stenting at EPP
– Allows ventilation of obstructed
airspaces via collaterals
– Airway wall vibration loosens
secretions

http://bronchiectasis.com.au/wpcontent/uploads/2015/09/Collateral-Ventilation.png

https://d1yboe6750e2cu.cloudfront.net

• Devices
– Non-oscillating
• One-way valve and variable
airflow resistor
• High (25-100 cm H2O) or
low (5-20) pressure
– Oscillating
• Various designs
– Variable pressure
– Variable frequency

• Therapy

– Tidal breathing for 10-15
breaths
– 15-20 breaths against
resistance
– FET/Cough/Huff
– Repeat
– 20-30 minutes total

• Pro
–
–
–
–
–
–

Active
Independence
Five years and older
Low cost
Portable
Easy to use

• Con
– ????

• Data
– Most trials suggest
equivalence to other forms of
airway clearance and
possible superiority to PDP
– Variable results for sputum
clearance
– High patient acceptance

Intrapulmonary Percussive
Ventilation
• Physiology
– Benefits of PEP
– Benefits of airway vibration

• Device
– Variable pressure and frequency
– Used with mouthpiece or mask
– Aerosol therapy may be done inline

• Therapy
– Generally 15-20
minute therapy
sessions
– Controlled breathing
and huffing between
IPV breaths

• Pro
– Most useful for atelectasis
and neuromuscular patients

• Con
– Cost
– Lack of portability
– Not easy to use

• Data
– Several studies
demonstrating equivalence to
PDP
– More sputum production than
IS in neuromuscular patients
– Benefits in COPD

Insufflation/Exsufflation
• Physiology
– Positive inhalation and negative exhalation
pressures
• Improves chest wall expansion
• Improves collateral ventilation
• Suctions secretions from large airways

• Device
–
–
–
–
–

Variable pressures/flow
Variable inhalation/exhalation times
Pause time
Different interfaces
Inline aerosol therapy

• Therapy
– Positive pressure inspiratory
breaths (5-6) followed by a
negative pressure expiratory
breath
– 15-20 minutes of therapy
– Generally recommend BID when
well and up to every three hours

when sick

• Pro
– Most beneficial for muscle
weakness diseases

• Con
– Cost
– Patient cooperation essential
– May not be well tolerated

• Data
– Numerous studies in several
neuro-muscular diseases
– Decreased hospitalization
rate, increased secretion
clearance, decreased
atelectasis

Choosing the Right AACT
• Obstructive diseases
PDP

Birth

PEP/OPEP
HFCWO
ACBT
FET/Huff

2 yr

4 yr

6 yr

• Restrictive diseases
– Insufflator/Exsufflator

8 yr

IPV
AD

10 yr

12 yr

• Consider
–
–
–
–
–

Cost
Convenience
Patient preference
Proven disease-specific efficacy
Subjective patient-specific efficacy
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